BFC
OREX

Bedel Financial Consulting’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Bedel Financial Consulting’s Portfolio OREX Stock Details OREX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-400
Closed – – 747
2018
Q1 		$0 Buy
+400
New +$369 ﹤0.01% 707

Other funds holding OREX

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Bedel Financial Consulting's OREX Position: Q2 2018 in Review

Bedel Financial Consulting sold out of Orexigen Therapeutics, Inc. (OREX) in Q2 2018, closing a stake of 400 shares.

Bedel Financial Consulting first reported a position in OREX in Q1 2018 and held it in 1 quarter. The position peaked at $0 in Q1 2018. 4 funds tracked by Wall St. Rank hold OREX as of Q2 2018.

  • Bedel Financial Consulting reported no remaining Orexigen Therapeutics, Inc. position as of Q2 2018 after selling out during the quarter.
  • Bedel Financial Consulting sold 400 Orexigen Therapeutics, Inc. shares in Q2 2018.
  • Bedel Financial Consulting first reported a position in Orexigen Therapeutics, Inc. in Q1 2018 and held it in 1 quarter.
  • Bedel Financial Consulting's Orexigen Therapeutics, Inc. position peaked at $0 in Q1 2018.
  • 4 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q2 2018.

Based on Bedel Financial Consulting's 13F filing for Q2 2018, filed 18 Jul 2018.